skip to Main Content

Ikan Biotech is a company specialized in the design and development of zebrafish in vivo models and new antimicrobial products.

Our cutting-edge technologies allow us to support our customers with solutions in their discovery and development of innovative products in Human and Animal Healthcare.

"ZEBRAFISH IN VIVO MODELS"
Toxicity Assay - IBD Model - Infection Model - Xenograft Model

Toxicity models

Acute toxicity
Chronic toxicity
Cardiotoxicity
Hepatotoxicity
Neurotoxicity

IBD model

Molecular analysis
Histological analysis

Infection models

Efficacy
Safety
Gram postive models
Gram negative models

Tumor models

Xenograft avatar (zPDX)
Spheroids assay
Cytotoxicity assay
Cell migration capacities
Gene expression assay

PHAGETHERAPY

NATURAL ENDOLYSINS

CHIMERIC ENDOLYSINS

WHY CHOOSE US?

Through our continuous internal R&D, combine our expertise in zebrafish together with different therapeutic areas Ikan Biotech has developed several innovative Zebrafish Models which help to reduce the cost of the drug discovery phase.

Our IBD Model is a useful tool to study bioactive drugs that modulate acute inflammation.

Our Infection Model (Gram-positive and Gram-negative bacteria) contributes to analyzing the antibacterial effects of a given target compound.

Ikan Biotech has solutions for oncology research with our Xenograft Model, that allows us to microinject tumour cells in zebrafish. This is an efficient tumour model system to design and test the efficacy of potential drugs for the treatment of cancer.

Last Zebrafish Model but not least, the well-known Toxicity Assay to evaluate the safety and identify possible adverse effects on drug candidates at early stages of drug development.

Certificates

ISO 9001:2015

ISO 9001:2015

UNE 166002:2014

UNE 166002:2014

Innovative SME

Innovative SME

Crédit Impôt Recherche (CIR)

Crédit Impôt Recherche (CIR)